David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Discover the full record of transactions filed by David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust, Director. Officer active across 1 company, notably Arovella Therapeutics Limited. Aggregated, 1 disclosures have been recorded. Regulator: ASX. The full history is accessible without signup.
Companies and markets linked to David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
About David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
David John Williams is a Board Member at Arovella Therapeutics Limited. In this role, he participates in the governance of the company and in strategic decision-making. His experience and skills are valuable for the development and growth of Arovella.